Early symptom progression rate is related to ALS outcome: a prospective population-based study.
Turner
Martin
M
Al-Chalabi
Ammar
A
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy / Q000503:physiopathology*; D000818:Animals; D016208:Databases, Factual; D018450:Disease Progression; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D011153:Population; D011446:Prospective Studies; D019782:Riluzole / Q000627:therapeutic use
D018696:Neuroprotective Agents; D019782:Riluzole